Pharmabiz

Lexeo Therapeutics reports progress in US FDA discussions for accelerated approval pathway for LX2006 in Friedreich ataxia cardiomyopathy

Lexeo Therapeutics reports progress in US FDA discussions for accelerated approval pathway for LX2006 in Friedreich ataxia cardiomyopathy: New York Saturday, October 11, 2025, 16: ...
Pharmabiz

Werewolf Therapeutics gets US FDA fast track designation for its investigational therapy WTX-124 for treatment of cancer

Werewolf Therapeutics gets US FDA fast track designation for its investigational therapy WTX-124 for treatment of cancer: Watertown, Massachusetts Saturday, October 11, 2025, 14:0 ...
Pharmabiz

ARS Pharmaceuticals receives favourable decision from EPO on nasal spray ‘neffy’ for emergency treatment of allergic reactions

ARS Pharmaceuticals receives favourable decision from EPO on nasal spray ‘neffy’ for emergency treatment of allergic reactions: San Diego Saturday, October 11, 2025, 13:00 Hrs ...
Pharmabiz

Chugai Pharma concludes license agreement with Roche for CT-388, a long-acting GLP-1/GIP receptor agonist

Chugai Pharma concludes license agreement with Roche for CT-388, a long-acting GLP-1/GIP receptor agonist: Tokyo Saturday, October 11, 2025, 11:00 Hrs [IST] Chugai Pharmaceutical ...
Pharmabiz

Nasus Pharma collaborates with Aptar to support development and commercialization of NS002

Nasus Pharma collaborates with Aptar to support development and commercialization of NS002: Tel Aviv Saturday, October 11, 2025, 12:00 Hrs [IST] Nasus Pharma Ltd, a clinical-stage ...
Pharmabiz

WHO announces the development of new recommendations on Human T-cell lymphotropic virus-1

The World Health Organization (WHO) is convening a Guideline Development Group (GDG) for the development of evidence-based recommendations on Human T-cell lymphotropic virus-1 (HTLV-1). HTLV-1 – the ...
Pharmabiz

AiMeD welcomes faster GST refunds; requests measures to enhance system

AiMeD welcomes faster GST refunds; requests measures to enhance system: Our Bureau, New Delhi Saturday, October 11, 2025, 08:30 Hrs [IST] The Association of Indian Medical Device ...
Pharmabiz

EY-Parthenon and FICCI unveils report on 'True Accountable Care: Maximizing Healthcare Delivery Impact, Efficiently’

EY-Parthenon and FICCI releases a report titled 'True Accountable Care: Maximizing Healthcare Delivery Impact, Efficiently’ ...
Pharmabiz

Kazia Therapeutics inks collaboration and in-licensing agreement with QIMR Berghofer for PD-L1 protein degrader programme

Sydney, Australia Friday, October 10, 2025, 16:00 Hrs [IST] ...
Pharmabiz

SC dismisses plea for CBI probe into deaths allegedly related contaminated cough syrup

SC dismisses plea for CBI probe into deaths allegedly related contaminated cough syrup: Our Bureau, New Delhi Friday, October 10, 2025, 15:45 Hrs [IST] The Supreme Court has dismi ...
Pharmabiz

Everstone Capital backed medtech Co, Integris Medtech files DRHP with SEBI for IPO

Everstone Capital backed medtech Co, Integris Medtech files DRHP with SEBI for IPO: Our Bureau, Bengaluru Friday, October 10, 2025, 16:40 Hrs [IST] Integris Medtech, the second la ...
Pharmabiz

Emalex Biosciences’ Expanded Access Programme for investigational Tourette syndrome drug, ecopipam receives US FDA authorization

Emalex Biosciences’ Expanded Access Programme for investigational Tourette syndrome drug, ecopipam receives US FDA authorization: Chicago Friday, October 10, 2025, 18:00 Hrs [IS ...